FPTI
FPTI is a SYT-SSX1 fusion protein modulator with selective cytotoxicity in SYT-SSX1-positive synovial sarcoma cells. FPTI down-regulates SYT-SSX1 expression and modulates its downstream target genes. FPTI induces apoptosis in synovial sarcoma cells. FPTI can be used for the research of synovial sarcoma.
For research use only. We do not sell to patients.
- CAS No.: 173374-58-8
- Formula: C15H10FN5
- Molecular Weight:279.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
FPTI (10-100 μM; 24-96 h) selectively reduces cell viability in SYT-SSX1-positive Yamato and ASKA synovial sarcoma cell lines with IC50 values of 33 μM and 39 μM, respectively, while showing weaker activity against non-synovial sarcoma and normal cell lines[1].
FPTI (10-40 μM; 72 h) modulates gene expression in SYT-SSX1-positive ASKA synovial sarcoma cells by downregulating SYT-SSX1 and key oncogenic downstream targets, while upregulating CDKN2A[1].
FPTI (10-40 μM; 24 h) induces apoptotic cell death in SYT-SSX1-positive ASKA synovial sarcoma cells in a concentration-dependent manner, with greater late-stage apoptosis observed at the 40 μM IC50 dose after 24 h[1].
FPTI (10-40 μM; 72 h) induces G0-G1 cell cycle arrest and increases apoptotic sub-G0 cell population in SYT-SSX1-positive ASKA synovial sarcoma cells after 72 h, with the strongest effect observed at the 40 μM IC50 dose[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Yamato (SYT-SSX1-positive synovial sarcoma), ASKA (SYT-SSX1-positive synovial sarcoma), HEK293 (immortalized embryonic kidney), 143B (sarcoma), A673 (sarcoma)
-
Concentration:10-100 μM (72 h); 40 μM (24, 48, 96 h)
-
Incubation Time:24 h, 48 h, 72 h, 96 h
-
Result:Reduced cell viability by 48.71% in HEK293, 67.35% in ASKA, and 72.48% in Yamato cells at 40 μM for 72 h compared to DMSO controls.
Showed insignificant cytotoxicity at 10 μM and 20 μM.
Induced cytotoxicity in HEK293 cells below 50% viability at 60, 80, 100 μM.
Showed no significant cytotoxicity in 143B or A673 cells.
Achieved IC50 values of 39 μM for ASKA, 33 μM for Yamato, 66 μM for HEK293, 64 μM for 143B, and 70 μM for A673.
-
Cell Line:ASKA (SYT-SSX1-positive synovial sarcoma)
-
Concentration:10 μM, 40 μM (72 h)
-
Incubation Time:72 h
-
Result:Downregulated expression of SYT-SSX1 and its downstream target genes cyclin D1 (CCDN1), β-catenin (CTNNB1), FZD, PDGFRA, COM1, SMARCB1, and P21 at 40 μM.
Induced dose-dependent repression of FZD, CCDN1, SMARCB1, and P21.
Downregulated EGFR and EGR1 only at 10 μM.
Upregulated CDKN2A with treatment.
-
Cell Line:ASKA (SYT-SSX1-positive synovial sarcoma)
-
Concentration:10 μM (IC10), 40 μM (IC50) (24 h)
-
Incubation Time:24 h
-
Result:Altered cell forward and side scatter parameters compared to untreated cells.
Increased cell death to over twice the basal level at 10 μM.
Increased cell death to thrice the basal level at 40 μM.
Induced a marked increase in dual Annexin V/PI staining indicative of late apoptosis at 40 μM.
-
Cell Line:ASKA (SYT-SSX1-positive synovial sarcoma)
-
Concentration:10 μM (non-lethal dose), 40 μM (IC50) (72 h)
-
Incubation Time:72 h
-
Result:Increased the sub-G0 cell population to 31.25% (from 5.385% in untreated cells) and reduced the G0-G1 population to 44.9% (from 69.1% in untreated cells) at 40 μM.
Left the S and G2/M phase populations nearly unchanged at 40 μM.
Increased the sub-G0 population to 15.3% and reduced the G0-G1 population to 53.5% at 10 μM.
Chemical Information
-
CAS No. 173374-58-8
-
Molecular Weight 279.27
-
Formula C15H10FN5
-
SMILES
FC1=CC=C2NC=C(C2=C1)C3=NN=NN3C4=CC=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)